Peter S Kozuch MD

Oncology•New York, NY

Gastrointestinal Cancer, Hematologic Oncology

Associate Professor, Medicine, Oncology, Icahn School of Medicine at Mount Sinai

Join to View Full Profile

10 Union Sq ESuite 4CNew York, NY 10003
Phone+1 212-844-8070

Education & Training

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1997 - 2000
Boston University Medical CenterResidency, Internal Medicine, 1994 - 1997
Drexel University College of MedicineClass of 1994

Certifications & Licensure

NY State Medical License 2000 - 2025
MA State Medical License 1997 - 2011
TX State Medical License 1999 - 2000
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2009-2014
New York Magazine: Top Doctors Castle Connolly, 2011

Clinical Trials

Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas Start of enrollment: 2004 Mar 01
Completed
Phase 1
Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer Start of enrollment: 2004 Jun 01
Terminated
Phase 2
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
Completed
Phase 3
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer Start of enrollment: 2004 Jul 01
Completed
Phase 2
Neo-Adjuvant FOLFOX for Rectal Carcinoma Start of enrollment: 2009 Jan 01
Terminated
Phase 2
Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2009 Sep 01
Completed
Phase 2
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol Start of enrollment: 2011 Dec 01
Terminated
Phase 2
METformin With a caRbOhydrate Restricted Diet in Combination With Platinum Based Chemotherapy in Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2013 Sep 01
Join now to see all

Publications & Presentations

PubMed

Multiplexed immunohistochemical analysis of the immune microenvironment of biliary tract cancers pre- & post-neoadjuvant chemotherapy: case series.
Sirish Dharmapuri, Rafael Cabal, Guray Akturk, Giorgio Ioannou, Sinem Ozbey
Annals of Translational Medicine. 2024-08-01
14 citations
Effects of a Communication Intervention Randomized Controlled Trial to Enable Goals-of-Care Discussions
Nina A. Bickell, Anthony L. Back, Kerin B. Adelson, Jason Gonsky, Natalia N. Egorova
JCO Oncology Practice. 2020-05-06
40 citations
Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial.
Anish B. Parikh, Peter Kozuch, Nicholas Rohs, Daniel Becker, Benjamin Levy
Investigational New Drugs. 2017-09-22

Press Mentions

New Technology Tests Tumors Inside the Patient to Find Best TreatmentApril 22nd, 2015

Peter S Kozuch MD

Dr. Kozuch is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.